About BioTissue
BioTissue is a company based in Miami (United States) founded in 2001 by Amy Tseng and Scheffer CG Tseng. It operates as a Direct-to-Consumer (D2C), and Professional Services. BioTissue has raised $110.04 million across 19 funding rounds from investors including HHS, EW Healthcare Partners and Ballast Point Ventures. BioTissue offers products and services including Prokera, AmnioGraft, Neox 100, and Clarix 100. BioTissue operates in a competitive market with competitors including Annexon, Aldeyra, Nicox, Gyroscope and MeiraGTx, among others.
- Headquarter Miami, United States
- Founders Amy Tseng, Scheffer CG Tseng
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biotissue
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$110.04 M (USD)
in 19 rounds
-
Latest Funding Round
$4.42 M (USD), Grant
Jun 21, 2021
-
Investors
HHS
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioTissue
BioTissue offers a comprehensive portfolio of products and services, including Prokera, AmnioGraft, Neox 100, and Clarix 100. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Used for ocular healing with regenerative tissue technology.
Applied in ocular treatments for tissue regeneration support.
Utilized in surgical procedures for regenerative tissue healing.
Employed in surgical applications for tissue repair solutions.
Unlock access to complete
Unlock access to complete
Funding Insights of BioTissue
BioTissue has successfully raised a total of $110.04M across 19 strategic funding rounds. The most recent funding activity was a Grant round of $4.42 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 19
- Last Round Grant — $4.4M
-
First Round
First Round
(15 Sep 2006)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2021 | Amount | Grant - BioTissue | Valuation |
investors |
|
| Apr, 2019 | Amount | Series C - BioTissue | Valuation | EW Healthcare Partners | |
| Nov, 2016 | Amount | Grant - BioTissue | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioTissue
BioTissue has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, EW Healthcare Partners and Ballast Point Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage healthcare companies are invested in by EW Healthcare Partners.
|
Founded Year | Domain | Location | |
|
Expansion capital is provided by Ballast Point Ventures to growing companies.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioTissue
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioTissue
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biotissue Comparisons
Competitors of BioTissue
BioTissue operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Annexon, Aldeyra, Nicox, Gyroscope and MeiraGTx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
Drug candidates for immune-mediated diseases are developed by Aldeyra.
|
|
| domain | founded_year | HQ Location |
Nitric oxide-based therapeutics for glaucoma and eye conditions are developed.
|
|
| domain | founded_year | HQ Location |
Mobile SDK developed for app engagement and monetization strategies.
|
|
| domain | founded_year | HQ Location |
Gene therapies for ocular and neurodegenerative diseases are developed.
|
|
| domain | founded_year | HQ Location |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biotissue
Frequently Asked Questions about BioTissue
When was BioTissue founded?
BioTissue was founded in 2001 and raised its 1st funding round 5 years after it was founded.
Where is BioTissue located?
BioTissue is headquartered in Miami, United States. It is registered at Miami, Florida, United States.
Is BioTissue a funded company?
BioTissue is a funded company, having raised a total of $110.04M across 19 funding rounds to date. The company's 1st funding round was a Grant of $4.42M, raised on Sep 15, 2006.
What does BioTissue do?
BioTissue is engaged in the development and delivery of regenerative healing solutions using human birth tissue products. The company operates in the healthcare sector, specifically within biotechnology and regenerative medicine. Its offerings include ocular and surgical products such as Prokera, AmnioGraft, Neox, and Clarix, which are designed to support tissue repair and healing. Proprietary technologies like CryoTek are utilized to preserve the natural structure and biology of tissues. Research and development efforts are emphasized, with over 40 years of experience and more than 1 million clinical applications recorded.
Who are the top competitors of BioTissue?
BioTissue's top competitors include Annexon, Alimera Sciences and MeiraGTx.
What products or services does BioTissue offer?
BioTissue offers Prokera, AmnioGraft, Neox 100, and Clarix 100.
Who are BioTissue's investors?
BioTissue has 4 investors. Key investors include HHS, EW Healthcare Partners, Ballast Point Ventures, and River Cities Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.